Search Results - "Drawz, Paul E"

Heart Rate and Blood Pressure: Any Possible Implications for Management of Hypertension? by Reule, Scott, Drawz, Paul E.

“…Hypertension is a common clinical problem and a major risk factor for cardiovascular disease and stroke. Elevated heart rate is associated with elevated blood…”
Get full text

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT) by Rocco, Michael V., Sink, Kaycee M., Lovato, Laura C., Wolfgram, Dawn F., Wiegmann, Thomas B., Wall, Barry M., Umanath, Kausik, Rahbari-Oskoui, Frederic, Porter, Anna C., Pisoni, Roberto, Lewis, Cora E., Lewis, Julia B., Lash, James P., Katz, Lois A., Hawfield, Amret T., Haley, William E., Freedman, Barry I., Dwyer, Jamie P., Drawz, Paul E., Dobre, Mirela, Cheung, Alfred K., Campbell, Ruth C., Bhatt, Udayan, Beddhu, Srinivasan, Kimmel, Paul L., Reboussin, David M., Chertow, Glenn M.

“…Treating to a lower blood pressure (BP) may increase acute kidney injury (AKI) events. Data for AKI resulting in or during hospitalization or emergency…”
Get full text

Blood Pressure Measurement: Clinic, Home, Ambulatory, and Beyond by Drawz, Paul E., MD, MHS, MS, Abdalla, Mohamed, MD, Rahman, Mahboob, MD, MS

“…Blood pressure traditionally has been measured in the clinic setting using the auscultatory method and a mercury sphygmomanometer. Technologic advances have…”
Get full text

APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy by Bruggeman, Leslie A, Wu, Zhenzhen, Luo, Liping, Madhavan, Sethu, Drawz, Paul E, Thomas, David B, Barisoni, Laura, O'Toole, John F, Sedor, John R

“…African polymorphisms in the gene for Apolipoprotein L1 (APOL1) confer a survival advantage against lethal trypanosomiasis but also an increased risk for…”
Get full text

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function by Murray, Anne M., MD, MSc, Bell, Elizabeth J., PhD, MPH, Tupper, David E., PhD, Davey, Cynthia S., MS, Pederson, Sarah L., MA, MBA, Amiot, Elizabeth M., BA, Miley, Kathleen M., CNP, McPherson, Lauren, BS, Heubner, Brooke M., MS, Gilbertson, David T., PhD, Foley, Robert N., MBBS, Drawz, Paul E., MD, Slinin, Yelena, MD, MS, Rossom, Rebecca C., MD, MS, Lakshminarayan, Kamakshi, MD, PhD, Vemuri, Prashanthi, PhD, Jack, Clifford R., MD, Knopman, David S., MD

“…Background The Brain in Kidney Disease (BRINK) Study aims to identify mechanisms that contribute to increased risk for cognitive impairment in patients with…”
Get full text

CKD as a Model for Improving Chronic Disease Care through Electronic Health Records by Drawz, Paul E, Archdeacon, Patrick, McDonald, Clement J, Powe, Neil R, Smith, Kimberly A, Norton, Jenna, Williams, Desmond E, Patel, Uptal D, Narva, Andrew

“…Electronic health records have the potential to improve the care of patients with chronic medical conditions. CKD provides a unique opportunity to show this…”
Get full text

Effective Antimicrobial Stewardship in a Long-Term Care Facility through an Infectious Disease Consultation Service: Keeping a LID on Antibiotic Use by Jump, Robin L. P., Olds, Danielle M., Seifi, Nasim, Kypriotakis, Georgios, Jury, Lucy A., Peron, Emily P., Hirsch, Amy A., Drawz, Paul E., Watts, Brook, Bonomo, Robert A., Donskey, Curtis J.

“…Design. We introduced a long-term care facility (LTCF) infectious disease (ID) consultation service (LID service) that provides on-site consultations to…”
Get full text

Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial by Ghazi, Lama, Baker, Jason V, Sharma, Shweta, Jain, Mamta K, Palfreeman, Adrian, Necsoi, Coca, Murray, Daniel D, Neaton, James D, Drawz, Paul E

“…Abstract BACKGROUND The association between hypertension (HTN) and inflammatory biomarkers (interleukin-6 [IL-6] and high-sensitivity C-reactive protein…”
Get full text

Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients by Smith, Julia R, Hillman, Lisa, Drawz, Paul E

“…Evening dosing of antihypertensive medications lowers nighttime blood pressure, and in one large randomized trial, it reduced the risk for cardiovascular…”
Get full text

Medical records-based chronic kidney disease phenotype for clinical care and “big data” observational and genetic studies by Shang, Ning, Khan, Atlas, Polubriaginof, Fernanda, Zanoni, Francesca, Mehl, Karla, Fasel, David, Drawz, Paul E., Carrol, Robert J., Denny, Joshua C., Hathcock, Matthew A., Arruda-Olson, Adelaide M., Peissig, Peggy L., Dart, Richard A., Brilliant, Murray H., Larson, Eric B., Carrell, David S., Pendergrass, Sarah, Verma, Shefali Setia, Ritchie, Marylyn D., Benoit, Barbara, Gainer, Vivian S., Karlson, Elizabeth W., Gordon, Adam S., Jarvik, Gail P., Stanaway, Ian B., Crosslin, David R., Mohan, Sumit, Ionita-Laza, Iuliana, Tatonetti, Nicholas P., Gharavi, Ali G., Hripcsak, George, Weng, Chunhua, Kiryluk, Krzysztof

“…Chronic Kidney Disease (CKD) represents a slowly progressive disorder that is typically silent until late stages, but early intervention can significantly…”
Get full text

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT by Ghazi, Lama, Pajewski, Nicholas M, Rifkin, Dena E, Bates, Jeffrey T, Chang, Tara I, Cushman, William C, Glasser, Stephen P, Haley, William E, Johnson, Karen C, Kostis, William J, Papademetriou, Vasilios, Rahman, Mahboob, Simmons, Debra L, Taylor, Addison, Whelton, Paul K, Wright, Jackson T, Bhatt, Udayan Y, Drawz, Paul E

“…Background Blood pressure ( BP ) varies over time within individual patients and across different BP measurement techniques. The effect of different BP targets…”
Get full text

Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States by Murphy, Daniel P, Drawz, Paul E, Foley, Robert N

“…Although hypertension is common in CKD and evidence-based treatment of hypertension has changed considerably, contemporary and nationally representative…”
Get full text

Impact of a chronic kidney disease registry and provider education on guideline adherence--a cluster randomized controlled trial by Drawz, Paul E, Miller, R Tyler, Singh, Simran, Watts, Brook, Kern, Elizabeth

“…Low adherence to chronic kidney disease (CKD) guidelines may be due to unrecognized CKD and lack of guideline awareness on the part of providers. The goal of…”
Get full text

Kidney Function Decline in Young Adulthood and Subsequent 24-Hour Ambulatory Blood Pressure in Midlife: The CARDIA Study by Ghazi, Lama, Shimbo, Daichi, Jacobs, David R., Kramer, Holly, Cohen, Jordana B., Muntner, Paul, Yano, Yuichiro, Drawz, Paul E.

Get full text

BP Measurement Techniques: What They Mean for Patients with Kidney Disease by Thomas, George, Drawz, Paul E

“…Patients with CKD typically have hypertension. Manual BP measurement in the office setting was used to define hypertension, establish eligibility, and assess…”
Get full text

Masked Uncontrolled Hypertension: MUCH Ado About Something by Drawz, Paul E

Get full text

The association between fine particulate matter (PM2.5) and chronic kidney disease using electronic health record data in urban Minnesota by Ghazi, Lama, Drawz, Paul E., Berman, Jesse D.

“…Background Recent evidence has shown that fine particulate matter (PM 2.5 ) may be an important environmental risk factor for chronic kidney disease (CKD), but…”
Get full text

BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols by Drawz, Paul E, Ix, Joachim H

“…Hypertension is the leading chronic disease risk factor in the world and is especially important in patients with CKD, nearly 90% of whom have hypertension…”
Get full text

Family History and Kidney Disease by Drawz, Paul E., MD, Sedor, John R., MD, Hostetter, Thomas H., MD

Get full text

Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease by Murphy, Daniel P, Wolfson, Julian, Reule, Scott, Johansen, Kirsten L, Ishani, Areef, Drawz, Paul E

“…Among patients with CKD, optimal use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after AKI is uncertain. Despite these…”
Get full text